At the University of Pennsylvania, researchers and clinicians have been aiming their energy and expertise at Ebola, searching in the lab for drugs to treat it, in the clinic for strategies to safely contain it, and in the field to understand the social and societal factors that bear on it.
The current study investigated the immunogenicity and protective response of rPA antigen formulated with the DPXTM no-release delivery platform (DPX-rPA). This unique formulation promotes a depot effect that attracts antigen-presenting cells to the vaccination site and elicits an immune response following single-dose delivery.
By developing a vaccine that targets specific cells in the immune system, researchers have seen a much greater immune and antibody response to the vaccine.
The US Biomedical Advanced Research and Development Authority (BARDA) has exercised another option under an ongoing contract for freeze-dried MVA-BN® smallpox vaccine.
A new study at the Tulane National Primate Research Center showed for the first time that an experimental drug can save nonhuman primates exposed to deadly ricin toxin.
Emergent BioSolutions NuThrax anthrax vaccine adsorbed with CPG 7909 Adjuvant is being studied for use as a third-generation anthrax vaccine.
Pirbright was designated as the world reference laboratory for foot-and-mouth disease (WRLFMD) by the Food and Agriculture Organization of the United Nations (FAO) in 1958. Over the past 60 years, the WRLFMD has played a leading role in coordinating international networks that improve laboratory diagnostic capacity and undertake global surveillance for FMD.
This reference sheet details Japanese encephalitis vaccination recommendations and reactions and risks.
This reference sheet details the types of anthrax, vaccination recommendations, and reactions and risks.
A Mississippi-based team of doctors is working on a telemedicine technology that could get emergency care to rural areas faster. It's an aerial ambulance: a drone named HiRO )Health Integrated Rescue Operations).